Stereotaxis has announced the CE mark submission for its MAGiC catheter, a robotically navigated magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures.
MAGiC is used in conjunction with Stereotaxis’ robotic systems and designed to provide catheter precision, stability and flexibility when diagnosing and treating cardiac arrhythmias, the company said in a press release.
MAGiC has been developed in collaboration with Osypka, a German medical devices company that pioneered the development of radiofrequency ablation of cardiac arrhythmias, and incorporates various features that are designed to enhance patient safety and efficacy, procedural efficiency, and the physician experience.
“The electrophysiology community has long awaited innovation in robotic catheter technology, and we are very excited by the near-term availability of the MAGiC catheter,” said Sabine Ernst (Royal Brompton & Harefield Hospitals and Imperial College London, London, UK). “I believe MAGiC will be a significant leap forward in clinical care for my patients and improved robotic performance.”
